Robert Beckmann’s latest exhibit “Transmutations: Robert Beckmann, Under the Western Sky 1977-2017,” is a retrospective that continues through April 9 at the Sahara West Library’s Studio. Las Vegas is well represented in the exhibit.
The Dam Short Film Festival, which has grown every year since first being presented in 2005, will screen 124 shorts Tuesday through Saturday at the historic Boulder Theatre.
The architect Joel Bergman worked on some of the most iconic resorts on the Las Vegas Strip, such as The Mirage. Now, that legacy is in the hands of his sons, Leonard and George Bergman. In this role, they’re creating resorts across the Midwest and West and updating rooms closer to home, at Caesars Palace, Paris Las Vegas and Planet Hollywood.
Chris Jacobs is a longtime local bartender and creator of the Beer Zombies blog, which has reviews of beers, a list of beers he’s trying to find and news from the craft-beer world. He also creates murals both here and elsewhere.
Patrick “Pulsar” Trout has been booking shows in Vegas since he was a kid just out of high school, when he brought coed rockers The Start to now-shuttered, all-ages music venue/coffee spot Rock N Java over 10 years ago.
General manager Craig Knight talks about the voice of urban Las Vegas and its leap from historic west Las Vegas to the reaches of cyberspace.
When the King of Rock ’n’ Roll passed away almost 40 years ago, he left behind records, concert performances and movies that show no signs of ever being forgotten.
“We’ve built a world-class, state-of-the-art museum that will rival any children’s museum or science museum in the country. But we have to make this a bigger part of the fabric of the community,” says Tifferney White, president and chief executive officer of Discovery Children’s Museum.
A portion of each ticket sold for Glittering Lights at the Las Vegas Motor Speedway goes to the nonprofit.
Dr. Kate Zhong is the chief strategy officer for the Global Alzheimer’s Platform Foundation, a Washington, D.C.-based organization that works to increase current and future enrollment in trials in Alzheimer’s, Parkinson’s and related diseases.